The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics

Linezolid is an antimicrobial agent for the treatment of multiresistant Gram-positive infections. We assessed the impact of linezolid on the microbiota and the emergence of resistance and investigated its relationship with plasma pharmacokinetics of the antibiotic. Twenty-eight patients were treated...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Bourgeois-Nicolaos, N., Nguyen, T. T., Defrance, G., Massias, L., Alavoine, L., Lefort, A, Noel, V., Senneville, E., Doucet-Populaire, F., Mentré, F., Andremont, A., Duval, X.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2014
Teme:
Clinical Therapeutics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3993229/
https://ncbi.nlm.nih.gov/pubmed/24566182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02251-13
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items